Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee, announced a Dec. 5 hearing on prescription drug shortages that will include testimony from two witnesses who have published research on the 340B program.

Senate Committee Doubles Down on PBM Bill with 340B Spread Pricing Language

Members of the Senate Finance Committee yesterday reiterated support for a pharmacy benefit manager (PBM) transparency bill with 340B spread [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at